TipRanks
Akari Therapeutics (DE:CLA1)
FRANKFURT:CLA1
Germany Market
CLA1
Akari Therapeutics
RESEARCH TOOLSreports

Akari Therapeutics (CLA1) Balance Sheet

0 Followers

Akari Therapeutics Balance Sheet

Akari Therapeutics's total assets for Q2 2026 were $38.62M, a decrease of -19.35% from the previous quarter. DE:CLA1 total liabilities were $20.03M for the fiscal quarter, a 2.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Assets
$ 47.89M$ 50.56M$ 4.36M$ 13.83M$ 11.65M
Total Liabilities
$ 19.56M$ 28.33M$ 4.58M$ 12.04M$ 6.09M
Total Equity Gross Minority
$ 28.33M$ 22.23M$ -229.00K$ 1.79M$ 5.55M
Other Metrics
Currency in USD

Akari Therapeutics Debt to Assets